Bargain hunters are wise to pay careful attention to insider
buying, because although there are many various reasons for an
insider to sell a stock, presumably the only reason they would use
their hard-earned dollars to make a purchase, is that they expect
to make money. Today we look at two noteworthy recent insider buys.
At PIMCO Dynamic Credit Income Fund (
), a filing with the SEC revealed that on Thursday, William H.
Gross bought 186,249 shares of PCI, for a cost of $23.52 each, for
a total investment of $4.38M. Gross was up about 0.8% on the
purchase at the high point of today's trading session, with PCI
trading as high as $23.71 in trading on Tuesday. PIMCO Dynamic
Credit Income Fund is trading up about 0.2% on the day Tuesday.
Before this latest buy, Gross bought PCI on 19 other occasions
during the past twelve months, for a total cost of $41.89M at an
average of $22.98 per share.
And on Friday, Director Deepika Pakianathan bought $3M worth of
Karyopharm Therapeutics (
), buying 114,419 shares at a cost of $26.18 each. Before this
latest buy, Pakianathan made one other buy in the past twelve
months, purchasing $5M shares at a cost of $16.00 each. Karyopharm
Therapeutics is trading up about 2.4% on the day Tuesday.
Pakianathan was up about 7.0% on the buy at the high point of
today's trading session, with KPTI trading as high as $28.02 at
last check today.
VIDEO: Tuesday 5/27 Insider Buying Report: PCI,